These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 861998)

  • 1. [Uses of silymarin in the treatment of symptomatic hepatic porphyria (author's transl)].
    Kordac V; Kaláb M
    Cas Lek Cesk; 1977 Apr; 116(13):407-10. PubMed ID: 861998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 4. [A two-center study on the effects of silymarin in pregnant women and adult patients with so-called minor hepatic insufficiency].
    Giannola C; Buogo F; Forestiere G; Scaffidi L; Ferrigno V; Scaffidi A
    Clin Ter; 1985 Jul; 114(2):129-35. PubMed ID: 4053531
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the therapeutic effects of silymarin].
    Margaroli P; Rossi M; Arcabasso GD; Cosini I; Malacrida C
    Clin Ter; 1980 Dec; 95(6):663-72. PubMed ID: 7214856
    [No Abstract]   [Full Text] [Related]  

  • 6. [Suburoporphyrins in symptomatic hepatic porphyria and in experimental porphyria (author's transl)].
    Kaláb M; Jirsa M; Kordac V; Soldátová H
    Cas Lek Cesk; 1981 Oct; 120(41):1251-4. PubMed ID: 7344798
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats].
    Siegers CP
    Z Gastroenterol; 1982 Dec; 20(12):757-8. PubMed ID: 7164529
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
    Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R
    Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792
    [No Abstract]   [Full Text] [Related]  

  • 9. [Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies].
    De Martiis M; Fontana M; Assogna G; D'Ottavi R; D'Ottavi O
    Clin Ter; 1980 Aug; 94(3):283-315. PubMed ID: 7004762
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ambulatory treatment of hepatic damage: comparison of 2 therapeutic modalities].
    Ravetta A
    Clin Ter; 1981 Oct; 99(2):149-53. PubMed ID: 7318368
    [No Abstract]   [Full Text] [Related]  

  • 11. [Membrane protectors and silymarin in hepatology therapy].
    Grossi F; Viola F
    Clin Ter; 1981 Jan; 96(1):11-23. PubMed ID: 7016408
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of silymarin in the treatment of alcoholic hepatic steatosis].
    Canini F; Bartolucci L; Cristallini E; Gradoli C; Rossi A; Ribacchi R; Valori C
    Clin Ter; 1985 Aug; 114(4):307-14. PubMed ID: 4053546
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of chloroquine therapy on the level of porphyrins in the liver in symptomatic hepatic porphyria].
    Martásek P; Jirsa M; Kordac V
    Cesk Gastroenterol Vyz; 1982 Jun; 36(3-4):198-205. PubMed ID: 7105200
    [No Abstract]   [Full Text] [Related]  

  • 14. [Silymarin treatment of alcoholic liver disease].
    Orv Hetil; 1990 Jul; 131(29):1607-9. PubMed ID: 2392321
    [No Abstract]   [Full Text] [Related]  

  • 15. [2 years' experience with the treatment of symptomatic liver porphyria with pyrimethamine].
    Cervinka J; Kaláb M; Martásek P; Kotal P; Marecek Z; Jirsa M; Kordac V; Soldátová H
    Cas Lek Cesk; 1985 Aug; 124(35):1107-12. PubMed ID: 4028097
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of pyrimethamine on clinical and biochemical manifestations of symptomatic liver porphyria].
    Cervinka J; Kaláb M; Kordac V; Jirsa M; Martásek P; Papezová R
    Cas Lek Cesk; 1983 Apr; 122(16):487-90. PubMed ID: 6616532
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C; Petrea S; Băldescu R; Macarie E; Chiriloiu C; Purice S
    Med Interne; 1988; 26(4):311-22. PubMed ID: 3072661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural morphometric investigations on mouse liver after treatment with phalloidin and alpha-amanitin followed by application of silybin (author's transl)].
    Meiss R; Brauch F; Themann H
    Z Gastroenterol; 1981 Aug; 19(8):384-9. PubMed ID: 7281857
    [No Abstract]   [Full Text] [Related]  

  • 19. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
    Benda L; Dittrich H; Ferenzi P; Frank H; Wewalka F
    Wien Klin Wochenschr; 1980 Oct; 92(19):678-83. PubMed ID: 7008367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Porphyria cutanea tarda treated with low doses of antimalarial agents; liver findings (author's transl)].
    Chlumský J; Dobiás J; Chlumská A; Malina L
    Cas Lek Cesk; 1977 Nov; 116(45):1404-6. PubMed ID: 603887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.